Big news out today! SCHAUMBURG, Ill., March 29, 2017

New Post Public Reply Private Reply Replies (1) Message Board
DiamondsInTheRough
150
Big news out today! SCHAUMBURG, Ill., March 29, 2017 /PRNewswire/ -- DOCASA, Inc. (DCSA), through its award-winning subsidiary, Department of Coffee and Social Affairs Limited, based in the United Kingdom ("UK", has announced the securing of its first coffee shop site in Manchester, UK. The new site is located on the ground floor of Faulkner House, a 25,000 sq. ft. building of serviced offices, in Manchester's iconic Piccadilly Gardens area.

The new site, comprising nearly 3,000 square feet of space and offering 120 covers, will be the Department of Coffee and Social Affairs' flagship store and barista training hub in the northern part of England. It will also act as a co-work space for professionals, with hot desks, breakout spaces and meeting rooms available to rent by the hour.

Commenting on the new site, DOCASA, Inc.'s President & CEO, Ashley Lopez, said: "We are thrilled to be opening in Manchester, a city with such a dynamic business and arts culture and one we have been looking to locate in for some time; this is the first of several planned site openings here." She went on, "With 1.91 million professional freelancers in the UK, the increasing demand for flexible workspace is constantly growing. Manchester is no exception to the trend, and we are capitalizing on this demand by dedicating space in our new site to cater for those professionals who need alternative work space."

Manchester, the UK's second largest city with 2.6 million people, is known for its flourishing music, culture and arts scene. In the past decade, the population has grown by about 17%, approximately double the UK growth rate. Based on the latest Hometrack research report released this month, Manchester also tops UK cities for having the strongest home price growth: 8.8% year-on-year. The city is home to over 100,000 businesses with an economy generating an annualized $70 billion.

About DOCASA, Inc.

DOCASA, Inc. is focused on the investment in a rapidly growing specialty coffee market principally in the United Kingdom. Through its subsidiary, Department of Coffee and Social Affairs Limited, headquartered in London, England, it has established and is growing an award-winning, market leading UK specialty coffee shop and online retail business. DOCASA is also pursuing the franchising and/or licensing of its branded shops and premium product offering outside of the UK to countries where the premium coffee market is rapidly expanding. The company continues to review opportunities in the broader international coffee market.

The Coffeesmiths Collective Inc. (COFE) Stock Research Links

COFE Board Company Profile Buy Rating Time & Sales News Filings Financials
Disclaimer must be read and fully understood ~ ALL POST SHOULD BE CONSIDERED COMPENSATED AWARENESS/MARKETING POSTS. THESE POSTS ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT SOLICITATIONS!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Microfluidics Market Growth: Insights and Future Trends

Updated Category News Views 112

Microfluidics Market Overview The global microfluidics market, valued at approximately USD 21.36 billion, is set for impressive growth. Predictions suggest it will reach about USD 32.67 billion by the end of 2029. This significant expansion is a clear indicator of the transformation occurring within diagnostics, life sciences, and pharmaceutical research. Driving Forces...

Continue Reading
How a $1000 Investment in Primerica Can Grow Over Time

Updated Category News Views 333

The Incredible Growth of Primerica Primerica (NYSE: PRI) has truly left a mark in the financial sector, showcasing remarkable performance over the last decade. With an annualized return of 17.97%, it has outperformed the market by 7.08%, demonstrating its strong foundational growth and investment appeal. As of now, Primerica holds a market capitalization of $9.18 billion,...

Continue Reading
Illumina Joins Forces with MyOme: A Game Changer in Healthcare

Updated Category News Views 115

Illumina and MyOme Collaboration Overview Illumina has recently entered into a significant collaboration deal with MyOme, a company specializing in genomic analysis. This partnership isn't just a strategic investment; it's an aerospace-like synergy aimed at transforming how healthcare operates in the United States. With a bold vision, the duo is set to explore innovative...

Continue Reading
BlackSky Technology Secures Major Contract Boosting Stock Appeal

Updated Category News Views 117

BlackSky Technology Gains Momentum After Major Contract Win BlackSky Technology Inc (BKSY) has seen its shares trade higher recently thanks to the remarkable announcement of a five-year contract with the U.S. National Geospatial-Intelligence Agency (NGA). This contract, valued at up to $290 million, will enable BlackSky to leverage its advanced satellite monitoring...

Continue Reading
BioXcel Therapeutics to Showcase Innovations at Conference

Updated Category News Views 255

BioXcel Therapeutics: AI in Medicine BioXcel Therapeutics, Inc. (NASDAQ: BTAI) is making waves in the biopharmaceutical sector using artificial intelligence (AI) to forge new paths in neuroscience medication. The CEO, Vimal Mehta, Ph.D., will take the stage at the highly regarded Canaccord Genuity 45th Annual Growth Conference. This pivotal event will take place in...

Continue Reading